results good this is going to fly, page-16

One point of interest is that they mention "Analysis of the final 48-week data showed 160 mg of PI-88 to be safe and tolerable and showed that treated patients had an increase in the chance of remaining disease free"

Which is true, however those on 250 mg showed a decreased chance of remaining disease free.

Which kind of casts doubts on it's effectiveness on that arm of the study.

However the rest of the data was good.

Best wishes to holders!